Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1337 entries
Sorted by: Best Match Show Resources per page
[Vacuum forming machine for radiotherapy (author's transl)].

Rinsho hoshasen. Clinical radiography

Hareyama M, Sakurai T, Nishio M, Saito A, Sakawa K, Kagami Y, Niijima K, Koshiba R, Saito C.
PMID: 7311073
Rinsho Hoshasen. 1981 Sep;26(9):993-5.

No abstract available.

Cite
Hareyama M, Sakurai T, Nishio M, et al. [Vacuum forming machine for radiotherapy (author's transl)]. Rinsho Hoshasen. 1981;26(9):993-5
Hareyama, M., Sakurai, T., Nishio, M., Saito, A., Sakawa, K., Kagami, Y., Niijima, K., Koshiba, R., & Saito, C. (1981). [Vacuum forming machine for radiotherapy (author's transl)]. Rinsho hoshasen. Clinical radiography, 26(9), 993-5.
Hareyama, M, et al. "[Vacuum forming machine for radiotherapy (author's transl)]." Rinsho hoshasen. Clinical radiography vol. 26,9 (1981): 993-5.
Hareyama M, Sakurai T, Nishio M, Saito A, Sakawa K, Kagami Y, Niijima K, Koshiba R, Saito C. [Vacuum forming machine for radiotherapy (author's transl)]. Rinsho Hoshasen. 1981 Sep;26(9):993-5. Japanese. PMID: 7311073.
Copy Download .nbib Format: NLM
Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan.

Archives of virology

Wen L, Nakayama M, Yamanishi Y, Nishio O, Fang Z-, Nakagomi O, Araki K, Nishimura S, Hasegawa A, Müller WEG, Ushijima H.
PMID: 28879402
Arch Virol. 1997 Jul;142(7):1481-1489. doi: 10.1007/s007050050174.

Sequence analysis of the VP7 gene was performed on twenty-one human isolates of serotype 3 related-rotavirus in China and Japan. The five Chinese isolates were found to be not similar to the 16 Japanese isolates and to SAff11 (simian...

Cite
Wen L, Nakayama M, Yamanishi Y, et al. Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Arch Virol. 1997;142(7):1481-1489doi: 10.1007/s007050050174.
Wen, L., Nakayama, M., Yamanishi, Y., Nishio, O., Fang, Z. -., Nakagomi, O., Araki, K., Nishimura, S., Hasegawa, A., Müller, W. E. G., & Ushijima, H. (1997). Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Archives of virology, 142(7), 1481-1489. https://doi.org/10.1007/s007050050174
Wen, L, et al. "Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan." Archives of virology vol. 142,7 (1997): 1481-1489. doi: https://doi.org/10.1007/s007050050174
Wen L, Nakayama M, Yamanishi Y, Nishio O, Fang Z-, Nakagomi O, Araki K, Nishimura S, Hasegawa A, Müller WEG, Ushijima H. Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Arch Virol. 1997 Jul;142(7):1481-1489. doi: 10.1007/s007050050174. PMID: 28879402.
Copy Download .nbib Format: NLM
Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD.

International journal of chronic obstructive pulmonary disease

Nishio M, Nakane K, Tanaka Y.
PMID: 27660430
Int J Chron Obstruct Pulmon Dis. 2016 Sep 06;11:2125-2137. doi: 10.2147/COPD.S110504. eCollection 2016.

BACKGROUND: Homology is a mathematical concept that can be used to quantify degree of contact. Recently, image processing with the homology method has been proposed. In this study, we used the homology method and computed tomography images to quantify...

Cite
Nishio M, Nakane K, Tanaka Y. Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2125-2137doi: 10.2147/COPD.S110504.
Nishio, M., Nakane, K., & Tanaka, Y. (2016). Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. International journal of chronic obstructive pulmonary disease, 112125-2137. https://doi.org/10.2147/COPD.S110504
Nishio, Mizuho, et al. "Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD." International journal of chronic obstructive pulmonary disease vol. 11 (2016): 2125-2137. doi: https://doi.org/10.2147/COPD.S110504
Nishio M, Nakane K, Tanaka Y. Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. Int J Chron Obstruct Pulmon Dis. 2016 Sep 06;11:2125-2137. doi: 10.2147/COPD.S110504. eCollection 2016. PMID: 27660430; PMCID: PMC5019166.
Copy Download .nbib Format: NLM
A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction.

Science (New York, N.Y.)

Seitz LC, Dickens CF, Nishio K, Hikita Y, Montoya J, Doyle A, Kirk C, Vojvodic A, Hwang HY, Norskov JK, Jaramillo TF.
PMID: 27701108
Science. 2016 Sep 02;353(6303):1011-1014. doi: 10.1126/science.aaf5050.

Oxygen electrochemistry plays a key role in renewable energy technologies such as fuel cells and electrolyzers, but the slow kinetics of the oxygen evolution reaction (OER) limit the performance and commercialization of such devices. Here we report an iridium...

Cite
Seitz LC, Dickens CF, Nishio K, et al. A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science. 2016;353(6303):1011-1014doi: 10.1126/science.aaf5050.
Seitz, L. C., Dickens, C. F., Nishio, K., Hikita, Y., Montoya, J., Doyle, A., Kirk, C., Vojvodic, A., Hwang, H. Y., Norskov, J. K., & Jaramillo, T. F. (2016). A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science (New York, N.Y.), 353(6303), 1011-1014. https://doi.org/10.1126/science.aaf5050
Seitz, Linsey C, et al. "A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction." Science (New York, N.Y.) vol. 353,6303 (2016): 1011-1014. doi: https://doi.org/10.1126/science.aaf5050
Seitz LC, Dickens CF, Nishio K, Hikita Y, Montoya J, Doyle A, Kirk C, Vojvodic A, Hwang HY, Norskov JK, Jaramillo TF. A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science. 2016 Sep 02;353(6303):1011-1014. doi: 10.1126/science.aaf5050. PMID: 27701108.
Copy Download .nbib Format: NLM
Critical Involvement of Environmental Carbon Dioxide Fixation to Drive Wax Ester Fermentation in Euglena.

PloS one

Padermshoke A, Ogawa T, Nishio K, Nakazawa M, Nakamoto M, Okazawa A, Kanaya S, Arita M, Ohta D.
PMID: 27669566
PLoS One. 2016 Sep 26;11(9):e0162827. doi: 10.1371/journal.pone.0162827. eCollection 2016.

Accumulation profiles of wax esters in Euglena gracilis Z were studied under several environmental conditions. The highest amount of total wax esters accumulated under hypoxia in the dark, and C28 (myristyl-myristate, C14:0-C14:0) was prevalent among all conditions investigated. The...

Cite
Padermshoke A, Ogawa T, Nishio K, et al. Critical Involvement of Environmental Carbon Dioxide Fixation to Drive Wax Ester Fermentation in Euglena. PLoS One. 2016;11(9):e0162827doi: 10.1371/journal.pone.0162827.
Padermshoke, A., Ogawa, T., Nishio, K., Nakazawa, M., Nakamoto, M., Okazawa, A., Kanaya, S., Arita, M., & Ohta, D. (2016). Critical Involvement of Environmental Carbon Dioxide Fixation to Drive Wax Ester Fermentation in Euglena. PloS one, 11(9), e0162827. https://doi.org/10.1371/journal.pone.0162827
Padermshoke, Adchara, et al. "Critical Involvement of Environmental Carbon Dioxide Fixation to Drive Wax Ester Fermentation in Euglena." PloS one vol. 11,9 (2016): e0162827. doi: https://doi.org/10.1371/journal.pone.0162827
Padermshoke A, Ogawa T, Nishio K, Nakazawa M, Nakamoto M, Okazawa A, Kanaya S, Arita M, Ohta D. Critical Involvement of Environmental Carbon Dioxide Fixation to Drive Wax Ester Fermentation in Euglena. PLoS One. 2016 Sep 26;11(9):e0162827. doi: 10.1371/journal.pone.0162827. eCollection 2016. PMID: 27669566; PMCID: PMC5036851.
Copy Download .nbib Format: NLM
New-Structure-Type Fe-Based Superconductors: CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs).

Journal of the American Chemical Society

Iyo A, Kawashima K, Kinjo T, Nishio T, Ishida S, Fujihisa H, Gotoh Y, Kihou K, Eisaki H, Yoshida Y.
PMID: 26943024
J Am Chem Soc. 2016 Mar 16;138(10):3410-5. doi: 10.1021/jacs.5b12571. Epub 2016 Mar 04.

Fe-based superconductors have attracted research interest because of their rich structural variety, which is due to their layered crystal structures. Here we report the new-structure-type Fe-based superconductors CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs),...

Cite
Iyo A, Kawashima K, Kinjo T, et al. New-Structure-Type Fe-Based Superconductors: CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs). J Am Chem Soc. 2016;138(10):3410-5doi: 10.1021/jacs.5b12571.
Iyo, A., Kawashima, K., Kinjo, T., Nishio, T., Ishida, S., Fujihisa, H., Gotoh, Y., Kihou, K., Eisaki, H., & Yoshida, Y. (2016). New-Structure-Type Fe-Based Superconductors: CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs). Journal of the American Chemical Society, 138(10), 3410-5. https://doi.org/10.1021/jacs.5b12571
Iyo, Akira, et al. "New-Structure-Type Fe-Based Superconductors: CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs)." Journal of the American Chemical Society vol. 138,10 (2016): 3410-5. doi: https://doi.org/10.1021/jacs.5b12571
Iyo A, Kawashima K, Kinjo T, Nishio T, Ishida S, Fujihisa H, Gotoh Y, Kihou K, Eisaki H, Yoshida Y. New-Structure-Type Fe-Based Superconductors: CaAFe4As4 (A = K, Rb, Cs) and SrAFe4As4 (A = Rb, Cs). J Am Chem Soc. 2016 Mar 16;138(10):3410-5. doi: 10.1021/jacs.5b12571. Epub 2016 Mar 04. PMID: 26943024.
Copy Download .nbib Format: NLM
Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension.

Journal of thoracic disease

Tamura K, Kishio N, Haruhara K, Uneda K, Azushima K, Wakui H.
PMID: 27500734
J Thorac Dis. 2016 Jul;8(7):E564-6. doi: 10.21037/jtd.2016.05.10.

No abstract available.

Cite
Tamura K, Kishio N, Haruhara K, et al. Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension. J Thorac Dis. 2016;8(7):E564-6doi: 10.21037/jtd.2016.05.10.
Tamura, K., Kishio, N., Haruhara, K., Uneda, K., Azushima, K., & Wakui, H. (2016). Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension. Journal of thoracic disease, 8(7), E564-6. https://doi.org/10.21037/jtd.2016.05.10
Tamura, Kouichi, et al. "Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension." Journal of thoracic disease vol. 8,7 (2016): E564-6. doi: https://doi.org/10.21037/jtd.2016.05.10
Tamura K, Kishio N, Haruhara K, Uneda K, Azushima K, Wakui H. Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension. J Thorac Dis. 2016 Jul;8(7):E564-6. doi: 10.21037/jtd.2016.05.10. PMID: 27500734; PMCID: PMC4958836.
Copy Download .nbib Format: NLM
Secondary aortoduodenal fistula identified by ultrasonography.

Journal of medical ultrasonics (2001)

Tsujimoto T, Hirai T, Kitaoka H, Hata M, Nishio K, Okuchi K, Yamashita N, Yoshida M, Fujii H, Fukui H.
PMID: 27278504
J Med Ultrason (2001). 2011 Jul;38(3):161-5. doi: 10.1007/s10396-011-0301-3. Epub 2011 Mar 26.

A 73-year-old man underwent coronary artery bypass grafting, abdominal aortic aneurysm resection, and prosthetic implantation as a single procedure in 2002. His progress was favorable until April 2008, when he was admitted to our hospital with melena. B-mode ultrasonography...

Cite
Tsujimoto T, Hirai T, Kitaoka H, et al. Secondary aortoduodenal fistula identified by ultrasonography. J Med Ultrason (2001). 2011;38(3):161-5doi: 10.1007/s10396-011-0301-3.
Tsujimoto, T., Hirai, T., Kitaoka, H., Hata, M., Nishio, K., Okuchi, K., Yamashita, N., Yoshida, M., Fujii, H., & Fukui, H. (2011). Secondary aortoduodenal fistula identified by ultrasonography. Journal of medical ultrasonics (2001), 38(3), 161-5. https://doi.org/10.1007/s10396-011-0301-3
Tsujimoto, Tatsuhiro, et al. "Secondary aortoduodenal fistula identified by ultrasonography." Journal of medical ultrasonics (2001) vol. 38,3 (2011): 161-5. doi: https://doi.org/10.1007/s10396-011-0301-3
Tsujimoto T, Hirai T, Kitaoka H, Hata M, Nishio K, Okuchi K, Yamashita N, Yoshida M, Fujii H, Fukui H. Secondary aortoduodenal fistula identified by ultrasonography. J Med Ultrason (2001). 2011 Jul;38(3):161-5. doi: 10.1007/s10396-011-0301-3. Epub 2011 Mar 26. PMID: 27278504.
Copy Download .nbib Format: NLM
Quantitative measurements of aortic valve coaptation by three-dimensional transesophageal echocardiography in patients with aortic regurgitation without primary leaflet disease.

Journal of echocardiography

Imai K, Watanabe N, Saito K, Hayashida A, Maehama T, Miyamoto Y, Kawamoto T, Neishi Y, Okura H, Yoshida K.
PMID: 27278539
J Echocardiogr. 2010 Mar;8(1):7-13. doi: 10.1007/s12574-009-0028-y. Epub 2009 Nov 14.

BACKGROUND: Aortic regurgitation (AR) without primary leaflet disease (functional AR) is known to occur as a result of loss of coaptation due to sinotubular junction (STJ) dilatation. However, the characteristics of change in the aortic valve coaptation length (AVCL)...

Cite
Imai K, Watanabe N, Saito K, et al. Quantitative measurements of aortic valve coaptation by three-dimensional transesophageal echocardiography in patients with aortic regurgitation without primary leaflet disease. J Echocardiogr. 2009;8(1):7-13doi: 10.1007/s12574-009-0028-y.
Imai, K., Watanabe, N., Saito, K., Hayashida, A., Maehama, T., Miyamoto, Y., Kawamoto, T., Neishi, Y., Okura, H., & Yoshida, K. (2010). Quantitative measurements of aortic valve coaptation by three-dimensional transesophageal echocardiography in patients with aortic regurgitation without primary leaflet disease. Journal of echocardiography, 8(1), 7-13. https://doi.org/10.1007/s12574-009-0028-y
Imai, Koichiro, et al. "Quantitative measurements of aortic valve coaptation by three-dimensional transesophageal echocardiography in patients with aortic regurgitation without primary leaflet disease." Journal of echocardiography vol. 8,1 (2010): 7-13. doi: https://doi.org/10.1007/s12574-009-0028-y
Imai K, Watanabe N, Saito K, Hayashida A, Maehama T, Miyamoto Y, Kawamoto T, Neishi Y, Okura H, Yoshida K. Quantitative measurements of aortic valve coaptation by three-dimensional transesophageal echocardiography in patients with aortic regurgitation without primary leaflet disease. J Echocardiogr. 2010 Mar;8(1):7-13. doi: 10.1007/s12574-009-0028-y. Epub 2009 Nov 14. PMID: 27278539.
Copy Download .nbib Format: NLM
Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Clinical and experimental nephrology

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S.
PMID: 27358079
Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5.

No abstract available.

Cite
Horie S, Mochizuki T, Muto S, et al. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016;20(4):510doi: 10.1007/s10157-016-1285-5.
Horie, S., Mochizuki, T., Muto, S., Hanaoka, K., Fukushima, Y., Narita, I., Nutahara, K., Tsuchiya, K., Tsuruya, K., Kamura, K., Nishio, S., Suwabe, T., Ubara, Y., Ishimura, E., Nakanishi, K., Furukawa, K., Kimura, K., & Matsuo, S. (2016). Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clinical and experimental nephrology, 20(4), 510. https://doi.org/10.1007/s10157-016-1285-5
Horie, Shigeo, et al. "Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014." Clinical and experimental nephrology vol. 20,4 (2016): 510. doi: https://doi.org/10.1007/s10157-016-1285-5
Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5. PMID: 27358079; PMCID: PMC6828247.
Copy Download .nbib Format: NLM
A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review.

Case reports in oncology

Iida K, Kawai N, Naiki T, Etani T, Ando R, Nagai T, Sugiyama Y, Naiki-Ito A, Nishio H, Okada A, Kohri K, Yasui T.
PMID: 26668577
Case Rep Oncol. 2015 Nov 01;8(3):530-5. doi: 10.1159/000442347. eCollection 2015.

Pemetrexed is an antifolate agent that is regarded as an alternative second-line chemotherapy against advanced or metastatic urothelial carcinoma (UC). However, there is limited information on pemetrexed in a third-line setting. We report a case of metastatic UC treated...

Cite
Iida K, Kawai N, Naiki T, et al. A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case Rep Oncol. 2015;8(3):530-5doi: 10.1159/000442347.
Iida, K., Kawai, N., Naiki, T., Etani, T., Ando, R., Nagai, T., Sugiyama, Y., Naiki-Ito, A., Nishio, H., Okada, A., Kohri, K., & Yasui, T. (2015). A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case reports in oncology, 8(3), 530-5. https://doi.org/10.1159/000442347
Iida, Keitaro, et al. "A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review." Case reports in oncology vol. 8,3 (2015): 530-5. doi: https://doi.org/10.1159/000442347
Iida K, Kawai N, Naiki T, Etani T, Ando R, Nagai T, Sugiyama Y, Naiki-Ito A, Nishio H, Okada A, Kohri K, Yasui T. A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review. Case Rep Oncol. 2015 Nov 01;8(3):530-5. doi: 10.1159/000442347. eCollection 2015. PMID: 26668577; PMCID: PMC4677708.
Copy Download .nbib Format: NLM
Erratum to: Impact of energy loss index on left ventricular mass regression after aortic valve replacement.

Journal of echocardiography

Koyama T, Okura H, Kume T, Fukuhara K, Imai K, Hayashida A, Neishi Y, Kawamoto T, Tanemoto K, Yoshida K.
PMID: 27279048
J Echocardiogr. 2014 Jun;12(2):59. doi: 10.1007/s12574-014-0208-2.

No abstract available.

Cite
Koyama T, Okura H, Kume T, et al. Erratum to: Impact of energy loss index on left ventricular mass regression after aortic valve replacement. J Echocardiogr. 2014;12(2):59doi: 10.1007/s12574-014-0208-2.
Koyama, T., Okura, H., Kume, T., Fukuhara, K., Imai, K., Hayashida, A., Neishi, Y., Kawamoto, T., Tanemoto, K., & Yoshida, K. (2014). Erratum to: Impact of energy loss index on left ventricular mass regression after aortic valve replacement. Journal of echocardiography, 12(2), 59. https://doi.org/10.1007/s12574-014-0208-2
Koyama, Terumasa, et al. "Erratum to: Impact of energy loss index on left ventricular mass regression after aortic valve replacement." Journal of echocardiography vol. 12,2 (2014): 59. doi: https://doi.org/10.1007/s12574-014-0208-2
Koyama T, Okura H, Kume T, Fukuhara K, Imai K, Hayashida A, Neishi Y, Kawamoto T, Tanemoto K, Yoshida K. Erratum to: Impact of energy loss index on left ventricular mass regression after aortic valve replacement. J Echocardiogr. 2014 Jun;12(2):59. doi: 10.1007/s12574-014-0208-2. PMID: 27279048; PMCID: PMC4969815.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1337 entries